Evidence mapPaperPMID 27465714Full record

ArticleMenopause (New York, N.Y.)2017

Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's Health Initiative.

Erin S LeBlanc, Kristopher Kapphahn, Haley Hedlin, Manisha Desai, Nisha I Parikh, Simin Liu, Donna R Parker, Matthew Anderson, Vanita Aroda, Shannon Sullivan and 4 more

Open access · greenAbstract read
In one paragraph

Article in Menopause (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
11.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. The Role of Estrogen across Multiple Disease Mechanisms.Current issues in molecular biology · 2024
    Review
  11. Article
  12. Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. The Associations between Upper and Lower Body Muscle Strength and Diabetes among Midlife Women.International journal of environmental research and public health · 2022
    Article
  18. Review
  19. Cumulative Endogenous Estrogen Exposure Is Associated With Postmenopausal Fracture Risk: The Women's Health Initiative Study.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  20. Asian Best Practices for Care of Diabetes in Elderly (ABCDE).The review of diabetic studies : RDS · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 1 country.

Erin S LeBlanc1Kaiser Permanente Center for Health Research, Portland, OR 2Stanford University School of Medicine, Stanford University, Stanford, CA 3University of California, San Francisco, San Francisco, CA 4Warren Alpert Medical School and School of Public Health of Brown University, Providence, RI 5Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Pawtucket, RI 6Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX 7MedStar, Washington Hospital Center, Washington, DC 8University of Washington School of Nursing, Seattle, WA 9University of Massachusetts Medical School, Worcester, MA 10Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL.
Kristopher Kapphahn
Haley Hedlin
Manisha Desai
Nisha I Parikh
Simin Liu
Donna R Parker
Matthew Anderson
Vanita Aroda
Shannon Sullivan
Nancy F Woods
Molly E Waring
Cora E Lewis
Marcia Stefanick
Stanford University · USKaiser Permanente Center for Health Research · USMedStar Washington Hospital Center · USBaylor College of Medicine · USBrown University · USMemorial Hospital of Rhode Island · USUniversity of California, San Francisco · USUniversity of Massachusetts Chan Medical School · USUniversity of Washington · US

Funding

UAB Diabetes Research CenterP30DK079626 · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2025 to 2025
$1.3M
NCATS NIH HHS KL2 TR000160NCATS NIH HHS UL1 TR001409NCATS NIH HHS UL1 TR001453NHLBI NIH HHS HHSN268201100001INHLBI NIH HHS HHSN268201100002INHLBI NIH HHS HHSN268201100003INHLBI NIH HHS HHSN268201100004INHLBI NIH HHS HHSN268201100046CNIA NIH HHS HHSN271201100004CNIDDK NIH HHS P30 DK079626WHI NIH HHS HHSN268201100001CWHI NIH HHS HHSN268201100002CWHI NIH HHS HHSN268201100003CWHI NIH HHS HHSN268201100004C
6 · The paper itself

Abstract

objectiveThe aim of the study was to understand the association between women's reproductive history and their risk of developing type 2 diabetes. We hypothesized that characteristics signifying lower cumulative endogenous estrogen exposure would be associated with increased risk.

methodsProspective cohort analysis of 124,379 postmenopausal women aged 50 to 79 years from the Women's Health Initiative (WHI). We determined age of menarche and final menstrual period, and history of irregular menses from questionnaires at baseline, and calculated reproductive length from age of menarche and final menstrual period. Presence of new onset type 2 diabetes was from self-report. Using multivariable Cox proportional hazards models, we assessed associations between reproductive variables and incidence of type 2 diabetes.

resultsIn age-adjusted models, women with the shortest (<30 y) reproductive periods had a 37% (95% CI, 30-45) greater risk of developing type 2 diabetes than women with medium-length reproductive periods (36-40 y). Women with the longest (45+ y) reproductive periods had a 23% (95% CI, 12-37) higher risk than women with medium-length periods. These associations were attenuated after full adjustment (HR 1.07 [1.01, 1.14] for shortest and HR 1.09 [0.99, 1.22] for longest, compared with medium duration). Those with a final menstrual period before age 45 and after age 55 had an increased risk of diabetes (HR 1.04; 95% CI, 0.99-1.09 and HR 1.08; 95% CI, 1.01-1.14, respectively) compared to those with age of final menstrual period between 46 and 55 years. Timing of menarche and cycle regularity was not associated with risk after full adjustment.

conclusionsReproductive history may be associated with type 2 diabetes risk. Women with shorter and longer reproductive periods may benefit from lifestyle counseling to prevent type 2 diabetes.

Indexed as

Reproductive HistoryWomen's HealthAgedDiabetes Mellitus, Type 2FemaleHumansIncidenceMenarcheMenstruationMiddle AgedPostmenopauseProportional Hazards ModelsProspective StudiesRisk FactorsSelf ReportTime Factors

Identifiers

PMID27465714
PMCPMC5477993
OpenAlexW2498892696

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.